These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1813205)

  • 1. Standardization and quality control of tumour marker assays.
    Ward AM
    Dis Markers; 1991; 9(3-4):127-32. PubMed ID: 1813205
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serodiagnosis: tumor marker].
    Yoneshima M; Hattori N; Sawabu N
    Gan No Rinsho; 1988 Aug; 34(10):1209-15. PubMed ID: 2459425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of present tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental and clinical evaluation of immunoradiometric assay (IRMA) for serum pancreatic oncofetal antigen (POA)].
    Ohba N; Hashimoto T; Nishibu M; Kashiwaya Y; Kawai K; Matsubara F; Miyazaki I
    Rinsho Byori; 1989 Feb; 37(2):153-8. PubMed ID: 2733181
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum diagnosis of cancer with monoclonal antibodies].
    Kannagi R
    Rinsho Byori; 1989 Jul; (Spec No 82):52-86. PubMed ID: 2575677
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of TAC-41 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M; Iwakoshi N; Kito K
    Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis.
    Springer GF; Desai PR; Wise W; Carlstedt SC; Tegtmeyer H; Stein R; Scanlon EF
    Immunol Ser; 1990; 53():587-612. PubMed ID: 1713069
    [No Abstract]   [Full Text] [Related]  

  • 8. Tn antigens and their significance in oncology.
    Lisowska E
    Acta Biochim Pol; 1995; 42(1):11-7. PubMed ID: 7653152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of a new marker and test systems for the diagnosis of lung cancer with a study of bronchoalveolar washings].
    Vikha GV; Romanova LK; Poletaeva OA; Meshandin AG; Timofeeva OI; Ovcharenko SI; Zavodnov VIa
    Ter Arkh; 1997; 69(3):50-2. PubMed ID: 9229832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic tumor diagnosis].
    Schmolke B
    Z Lymphol; 1990 Dec; 14(2):58-61. PubMed ID: 2087871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
    Sugano K; Okura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of ST 272 Ag detected by the monoclonal antibody, NCC-ST-272].
    Sekine T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1028-30. PubMed ID: 2192104
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor markers in pancreatic cancer--current concepts.
    Schmiegel W
    Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human anti-mouse antibodies: pitfalls in tumor marker measurement and strategies for enhanced assay robustness; including results with Elecsys CEA.
    Nussbaum S; Roth HJ
    Anticancer Res; 2000; 20(6D):5249-52. PubMed ID: 11326704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tumour marker measurements upon management of patients with carcinoma of the ovary.
    Rustin GJ
    Dis Markers; 1991; 9(3-4):153-8. PubMed ID: 1813207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (2)].
    Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1907-12. PubMed ID: 2439021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The detection of laryngeal carcinoma-associated antigens in tissue and serum using three mixed monoclonal antibodies against laryngeal cancer].
    Chen O; Guan G; Jin C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(1):43-6. PubMed ID: 9275404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic diagnosis of cancer--tumor markers].
    Kawai T
    Gan No Rinsho; 1989 Jan; Spec No():13-8. PubMed ID: 2915470
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basic and clinical evaluation of CA 130 RIA kit (D-7111) using two newly developed monoclonal antibodies; comparison with CA 125 kit].
    Saga T; Endo K; Nakashima T; Nakajima K; Matsuoka Y; Koizumi M; Kawamura Y; Watanabe Y; Hato A; Kunimatsu M
    Kaku Igaku; 1988 Oct; 25(10):1163-70. PubMed ID: 3221514
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fundamental studies, reference values, and clinical evaluation of abnormal prothrombin PIVKA-II assay using monoclonal antibody (E-1023)].
    Sakurabayashi I; Kawai T; Omizo R; Hattori N; Ishii M
    Rinsho Byori; 1988 Dec; 36(12):1407-12. PubMed ID: 2854864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.